Navigation Links
BioCrossroads Launches www.biocrossroadslinx.com and Releases Report on Biopharma Discovery and Development Contract Services
Date:2/28/2008

Web site includes searchable database of biotech contract service providers

INDIANAPOLIS, Feb. 28 /PRNewswire/ -- BioCrossroads, Indiana's initiative to grow the life sciences, has released an extensive report on major developments within the pharmaceutical and biotechnology industries holding significant promise for Indiana's continued life sciences growth. In addition, the initiative has launched a new Web site -- http://www.biocrossroadslinx.com -- offering a searchable database of comprehensive information about biopharma contract service providers and related university programs.

The 40-page report researches and spotlights the trend that, to combat the high costs and long lead times of product development and to manage scientific and business risks, both pharmaceutical and biotechnology companies are increasingly utilizing third party contract service providers (CSPs) as strategic partners for outsourced services necessary to bring a product to market. These services cover a wide range of drug development activities, including analytical testing, toxicology, clinical trial materials manufacturing, and regulatory consulting.

With the basic industry business model shifting from the traditional fully-integrated pharmaceutical company (FIPCO) that did everything from discovery to commercialization in house to a new "FIPNET" model creating a fully-integrated pharma network of sophisticated service providers, the opportunities for Indiana companies to expand services, employment and revenues across this sector are substantial. As the report documents, Indiana already features more than 40 CSPs serving this growing sector. Furthermore, of the 128 different activities identified in the report that advance the drug development process from discovery to commercialization, Indiana CSPs currently perform 112 of these services (with many planning additional service offerings within the nex
'/>"/>

SOURCE BioCrossroads
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ChemAxon Launches Marvin and JChem Version 5: Better User Experience, Better Integration, More Flexibility and Higher Performance
2. Coalition for a Competitive Pharmaceutical Market Launches New Print Ad Campaign Highlighting Need for Meaningful Biogenerics Legislation
3. Addressing the Pharmacist Shortage: Medco Labor Coalition(TM) Launches National Scholarship Program to Support the Development of the Next Generation of Pharmacists
4. Neogen Launches Quickest Test Available for Tetracyclines in Milk
5. Lucid Launches VivaNet(R) Telemedicine Server for Dermatology Applications
6. Arobella Medical, LLC Launches Qoustic Wound Therapy System(TM)
7. Barr Launches Generic Fosamax(R) Tablets, 70 mg
8. NHS Choices Launches New BMI Calculator
9. Oncothyreon launches new corporate website
10. Blue Cross and Blue Shield of Texas Launches an Integrated Medical-Dental Health Program
11. Arryx Launches HOTkit(TM) Complete for Dynamic, Scientific Manipulation of Microscopic Elements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... MA (PRWEB) December 18, 2014 iLab ... announced the appointment of Siri Bryant as the new ... new Director of Core Implementations. These two new leadership ... outstanding customer service by ensuring that iLab continues to ... “In the last four years, iLab has been deployed ...
(Date:12/19/2014)... BURLINGTON, Mass. , Dec. 18, 2014  Decision ... dental biomaterial market will grow moderately through ... implant procedures and growing awareness of dental biomaterials all ... underdeveloped markets such as China ... incomes will bring dental procedures within reach for a ...
(Date:12/17/2014)... (PRWEB) December 16, 2014 The ... since 2013, which is why IBISWorld updated its original ... continues to benefit from an intensified focus on environmental ... for new emission standards for power plants and a ... According to IBISWorld Industry Analyst Sarah Kahn, “a range ...
(Date:12/17/2014)... N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today announced ... (referred to as Somatuline®) was approved by the ... treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult ... advanced or metastatic disease to improve progression-free survival ...
Breaking Biology Technology:iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8
... Calif., Nov. 4, 2010 Onda Corporation, the global ... markets, introduced the latest additions to the hydrophone product ... The HFO-660 is a new fiber optic hydrophone system ... for emerging applications of HITU. It is complemented with ...
... EDISON, N.J., Nov. 4, 2010 International Technidyne Corporation ... THOR ), announced today the completion of its ... private equity firm, in an all cash transaction valued ... leader in hemostasis management and Point-of-Care (POC) testing for ...
... HOUSTON ― An antibody loaded with an anti-cancer agent produced ... relapsed or therapy-resistant Hodgkin lymphoma enrolled in a phase I ... the New England Journal of Medicine . "That ... a Phase I trial," said study lead author Anas Younes, ...
Cached Biology Technology:Onda Introduces a New Fiber Optic Hydrophone and Scanning Tank 2International Technidyne Corporation Acquired by Warburg Pincus 2International Technidyne Corporation Acquired by Warburg Pincus 3Armed antibody triggers remissions for Hodgkin's lymphoma 2Armed antibody triggers remissions for Hodgkin's lymphoma 3
(Date:12/10/2014)... 2014  Wake Forest Baptist Medical Center today announced plans ... of Medicine. Funding for this $50 million capital project ... be publicly launched next summer. The ... 60 series R.J. Reynolds Tobacco Company complex, adjacent to ... immediately with plans to be ready to welcome medical ...
(Date:12/5/2014)... Calif. , Dec. 4, 2014 ... has boosted investments in new testing and inspection ... also given rise to a range of innovative ... the requirements of Generation Y, which is generally ... As a result, product development strategies of test ...
(Date:12/3/2014)... -- As part of our commitment to offering the ... announce the release of a new reader that will ... data that they need. The Atlas 2000 ... readers. Many such devices have serious shortcomings when it ... models force users to navigate numerous complicated steps in ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Inception Technologies to Release New Biometric Reader 2
... PROVIDENCE, R.I. [Brown University] It,s been long known ... cells stabbed with spiky, long asbestos fibers, and the image ... cell, like a quivering arrow that,s found its mark. ... be interested in asbestos fibers and other materials at the ...
... ITHACA, N.Y. With an eye toward understanding DNA ... to actually unzip the two strands of DNA. (Nature, online ... processes, including DNA replication, are enzymes called helicases. Acting like ... prompting the strands to "zip" apart. What had been ...
... already led to major shifts in the abundance of commercially ... on September 15 in Current Biology , a Cell ... abundance of species as opposed to their presence or absence ... well on the European shelf than more northerly, cold-adapted species," ...
Cached Biology News:Why carbon nanotubes spell trouble for cells 2For unzipping DNA mysteries -- literally -- Cornell physicists discover how a vital enzyme works 2In rapidly warming seas, some fish lose while others gain 2
Immunogen: Synthetic peptide: N(171) H G F L S A D Q QL I K(183) Storage: -20 C, Avoid Freeze/Thaw Cycles...
The pCDF Expression System 1 plus Competent Cells contains 10 µg of pET-45b(+) DNA. pET-45b carries an N-terminal His•Tag ® coding sequence that is cleavable with enterokinase as well...
HIV-1 TAT (vN-21)...
Request Info...
Biology Products: